July 20, 2021

AlphaCT1 molecule may repair the skin's collagen matrix by altering how scar-forming cells behave

submited by
Style Pass
2021-07-21 02:00:03

July 20, 2021

by Whitney Slightham, Virginia Tech

Surgical scars treated with a molecule called alphaCT1 showed a long-term improvement in appearance when compared to control scars, according to multicenter, controlled Phase II clinical trials—a finding that could help surgeons improve patient outcomes.

Now, a public-private research team led by Rob Gourdie, professor and director of the Center for Vascular and Heart Research at the Fralin Biomedical Research Institute at VTC, has revealed clues about why and how it improves the appearance of scars.

Leave a Comment